Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.31B | 1.32B | 1.22B | 1.11B | 912.64M |
Gross Profit | 465.50M | 466.56M | 399.09M | 374.63M | 325.44M |
EBITDA | 175.40M | 236.10M | 215.91M | 219.73M | 209.70M |
Net Income | 170.10M | 140.15M | 137.31M | 132.10M | 102.62M |
Balance Sheet | |||||
Total Assets | 1.55B | 1.41B | 1.50B | 1.16B | 1.11B |
Cash, Cash Equivalents and Short-Term Investments | 263.81M | 243.96M | 228.99M | 319.55M | 309.31M |
Total Debt | 437.93M | 369.35M | 372.39M | 166.99M | 208.66M |
Total Liabilities | 709.78M | 647.03M | 703.31M | 410.49M | 422.06M |
Stockholders Equity | 837.72M | 765.73M | 801.14M | 754.00M | 684.09M |
Cash Flow | |||||
Free Cash Flow | 153.04M | 174.95M | 160.01M | 159.13M | 187.20M |
Operating Cash Flow | 207.16M | 229.24M | 204.96M | 187.45M | 213.73M |
Investing Cash Flow | -92.74M | -26.49M | -233.24M | -48.80M | -92.78M |
Financing Cash Flow | -89.77M | -237.97M | 63.03M | -127.12M | -117.76M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $3.47B | 19.24 | 21.21% | ― | -0.64% | 30.96% | |
78 Outperform | $39.66B | 16.94 | 16.61% | 1.54% | 4.09% | 14.05% | |
76 Outperform | $8.05B | 15.67 | 22.21% | 1.48% | 7.31% | -15.86% | |
76 Outperform | $3.57B | 15.56 | 5.59% | 2.35% | 11.31% | -16.02% | |
72 Outperform | $7.35B | 34.13 | 23.81% | ― | 14.18% | 21.49% | |
71 Outperform | $10.20B | 25.16 | 11.57% | ― | 4.72% | -3.06% | |
63 Neutral | $33.76B | 6.14 | -11.84% | 1.84% | 5.29% | -18.23% |
On July 6, 2025, WNS entered into a Transaction Agreement with Capgemini, under which Capgemini will acquire all outstanding shares of WNS for $76.50 per share, amounting to a total cash consideration of $3.3 billion. This acquisition, expected to close by the end of 2025, will position Capgemini as a leader in Intelligent Operations, leveraging Agentic AI to transform business processes. The transaction is anticipated to be accretive to Capgemini’s revenue growth and operating margin, with expected EPS accretion of 4% in 2026 and 7% in 2027. The deal has been unanimously approved by both companies’ boards and aims to enhance Capgemini’s capabilities in AI-powered business process transformation.
The most recent analyst rating on (WNS) stock is a Buy with a $67.00 price target. To see the full list of analyst forecasts on WNS stock, see the WNS Stock Forecast page.